More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$2.54B
EPS
1.4
P/E ratio
9.7
Price to sales
1.03
Dividend yield
--
Beta
2.035093
Previous close
$11.63
Today's open
$11.63
Day's range
$11.57 - $12.04
52 week range
$5.93 - $14.71
show more
CEO
Jeffrey Shaner
Employees
35500
Headquarters
Atlanta, GA
Exchange
Nasdaq Global Select
Shares outstanding
218409599
Issue type
Common Stock
Healthcare
Healthcare Providers & Services
Healthcare Stocks Overtake Tech: 5 Strong Buys Combining Growth And Value
Healthcare's emerging leadership combines defensive demand with long-term growth; the sector has gained over 22% year-to-date and more than 11% over one month. Five Quant Strong Buy stocks in the sector offer compelling growth opportunities, supported by strong earnings momentum, improving profitability, and positive analyst revisions. Healthcare services benefit from aging demographics, expanding patient demand, technological innovation, and operating efficiencies that support revenue growth and margin expansion.
Seeking Alpha • Nov 17, 2026

Aveanna Healthcare: Q3 Beat And Higher Guidance Back Strong Buy Rating
Aveanna Healthcare dipped despite a double earnings beat, but the growth outlook remains strong, backed by bullish Wall Street revisions. Private duty services drove earnings growth with hours of care increasing by more than double digits to 13 million amid a shift toward preferred payers. Revenue increased over 11% YoY in Q3 while adjusted EBITDA surged 25%, as the company demonstrated solid operating leverage.
Seeking Alpha • Nov 13, 2026

Should Value Investors Buy Aveanna Healthcare (AVAH) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks Investment Research • Nov 13, 2026

What Aveanna Healthcare (AVAH) Said on Its Q3 Earnings Call
Aveanna Healthcare NASDAQ: AVAH raised its full-year 2026 outlook after reporting third-quarter revenue growth across all three of its businesses and a 25% increase in adjusted earnings.
MarketBeat • Nov 12, 2026

Aveanna Healthcare Holdings Inc. (AVAH) Q3 2026 Earnings Call Transcript
Aveanna Healthcare Holdings Inc. ( AVAH ) Q3 2026 Earnings Call November 12, 2026 10:00 AM EST Company Participants Debbie Stewart - Senior VP & Principal Accounting Officer Jeffrey Shaner - President, CEO & Director Matt Buckhalter - CFO & Principal Financial Officer Conference Call Participants Meghan Holtz - Jefferies LLC, Research Division Benjamin Hendrix - RBC Capital Markets, Research Division Raj Kumar - Stephens Inc., Research Division Sean Dodge - BMO Capital Markets Equity Research Pito Chickering - Deutsche Bank AG, Research Division Benjamin Rossi - JPMorgan Chase & Co, Research Division Jared Haase - William Blair & Company L.L.C., Research Division Andrew Cooper - Raymond James Wealth Management Limited, Asset Management Arm Presentation Operator Good morning, and welcome to Aveanna Healthcare Holdings Third Quarter 2026 Earnings Conference Call.
Seeking Alpha • Nov 12, 2026

Aveanna Healthcare: Revenue Growth, Guidance Raises, Yet Shares Still Trade At A Discount
Aveanna Healthcare is rated Buy due to double-digit revenue growth, improved overhead leverage, and a favorable upcoming California rate increase. AVAH trades at a ~20% earnings discount to sector peers, reflecting concerns over leverage and Medicaid exposure, but the market underappreciates its growth. Rising caregiver wages, expanding nursing hours, and operational efficiencies support further upside, with California's 2027 rate hike as a credible tailwind.
Seeking Alpha • Nov 13, 2026

Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2026 Guidance
ATLANTA, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced financial results for the three and nine-month periods ended October 3, 2026.
GlobeNewsWire • Nov 12, 2026

Aveanna Healthcare (AVAH) Q3 Earnings and Revenues Beat Estimates
Aveanna Healthcare (AVAH) came out with quarterly earnings of $0.23 per share, beating the Zacks Consensus Estimate of $0.2 per share. This compares to earnings of $0.15 per share a year ago.
Zacks Investment Research • Nov 12, 2026

Compared to Estimates, Aveanna (AVAH) Q3 Earnings: A Look at Key Metrics
The headline numbers for Aveanna (AVAH) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks Investment Research • Nov 12, 2026

Aveanna Healthcare Just Keeps Raising The Bar
Aveanna Healthcare Holdings Inc. delivered another strong quarter, beating top- and bottom-line expectations and raising FY 2026 revenue and EBITDA guidance. AVAH's adjusted EBITDA grew 25% year-over-year, with margin expansion to 14.4%, demonstrating significant operating leverage and improved cash flow. Despite a substantial debt load and reimbursement risks, AVAH trades at the lowest forward PE and price-to-cash flow ratios among peers, reinforcing its Buy rating.
Seeking Alpha • Nov 12, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Aveanna Healthcare Holdings Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.